Hutch News

Hutch News

Stories tagged 'immunotherapy research'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 29, 2017

Dr. Jennifer Adair, a clinical researcher at Fred Hutch, spoke recently at TEDxNashville about her vision of making gene therapy more accessible and affordable for treating diseases ranging from glioblastoma to HIV.

View story >


Dr. Hootie Warren takes helm of Fred Hutch Global Oncology

Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care

July 6, 2017 | By Mary Engel / Fred Hutch News Service

Fred Hutch's new head of Global Oncology, Dr. Edus H. Warren, believes that the "breathtaking discoveries and advances" in immunotherapy and other areas that scientists are making here can be adapted to improve cancer care around the world.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 22, 2017

A new algorithm created by Dr. Philip Bradley and colleagues could aid the development of tools to decode T-cell receptor sequences and, ultimately, improve the diagnosis and treatment of cancers, reported this week in Nature.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 25, 2017

A team of Fred Hutch researchers led by principal investigator Dr. Eric Holland has received $400,000 for a two-year pilot study to test several novel immunotherapy approaches for glioma, an aggressive brain cancer. The study was made possible by the generous support of the Bezos family, which since 2009 has donated and leveraged more than $40 million to Fred Hutch for immunotherapy research.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 13, 2016

Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response.

View story >


New clues to treating deadly skin cancer

Small clinical trial finds two forms of immunotherapy may be better than one for treating metastatic melanoma

June 6, 2016 | By Rachel Tompa / Fred Hutch News Service

Matthew Flood, a retired EMT from the Tacoma Fire Department, is one of 10 patients with metastatic melanoma treated with an experimental combination of immunotherapies between 2011 and 2013. In a study published today in the Journal of Clinical Oncology, the research team described the small clinical trial and how the patients have fared in the years following their treatment. Flood is now in complete remission five years after receiving the combo immunotherapy.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.